JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB10579

Anti-TRF2 + TRF1 抗体 [TRF-78]

Anti-TRF2 + TRF1 antibody [TRF-78]

5

(10 Reviews)

|

(82 Publications)

Anti-TRF2 + TRF1 antibody [TRF-78] (ab10579) is a mouse monoclonal antibody detecting TRF1 in Western Blot, ICC/IF. Suitable for Human.

- Over 60 publications
- Trusted since 2004

別名を表示する

PIN2, TRBF1, TRF, TRF1, TERF1, Telomeric repeat-binding factor 1, NIMA-interacting protein 2, TTAGGG repeat-binding factor 1, Telomeric protein Pin2/TRF1

7 Images
Immunocytochemistry/ Immunofluorescence - Anti-TRF2 + TRF1 antibody [TRF-78] (AB10579)
  • ICC/IF

Collaborator

Immunocytochemistry/ Immunofluorescence - Anti-TRF2 + TRF1 antibody [TRF-78] (AB10579)

Immunofluorescent imaging of human cells (U2OS) with ab10579 confirms the specificity of this antibody. A few intense nuclear foci are seen in interphase cells, corresponding to telomeric localisation. The complete absence of background nuclear or cytoplasmic staining confirms the specificity of this antibody. This image is in exact agreement with numerous published reports.

IF was performed with a standard paraformaldehyde technique (fixed in PBS buffered PFH 4% for 5 minutes, permeabilised with 0.5% triton-PBS for 5 minutes, blocked with 5% milk / 0.2% tween for one hour. Primary antibody used at 1/100 in 5% milk / 0.2% TWEEN for one hour, secondary antibody for 30 minutes. All blocking and incubation steps carried out at 37 degrees. Nuclei are visualised using Hoechst stain.

This image is courtesy of Luke Hughes-Davies and Rhiannon Jade, Gurdon Institute, Cambridge, UK

Immunocytochemistry/ Immunofluorescence - Anti-TRF2 + TRF1 antibody [TRF-78] (AB10579)
  • ICC/IF

AbReview7136****

Immunocytochemistry/ Immunofluorescence - Anti-TRF2 + TRF1 antibody [TRF-78] (AB10579)

ab10579 at 1/500 staining human HeLa (Human epithelial cell line from cervix adenocarcinoma) cells by ICC/IF. The cells were parafomaldehyde fixed and blocked with BSA prior to incubation with the antibody for 45 minutes. An Alexa Fluor® 555 conjugated donkey anti-mouse antibody was used as the secondary.

This image is courtesy of an anonymous Abreview

Immunocytochemistry/ Immunofluorescence - Anti-TRF2 + TRF1 antibody [TRF-78] (AB10579)
  • ICC/IF

Supplier Data

Immunocytochemistry/ Immunofluorescence - Anti-TRF2 + TRF1 antibody [TRF-78] (AB10579)

Immunocytochemistry/ Immunofluorescence analysis of HeLa (Human epithelial cell line from cervix adenocarcinoma) cells labeling TRF1 and TRF2 with ab10579. Cells were fixed and permeabilized with 4% paraformaldehyde followed by 0.5% Triton X-100. Fixed cells were stained with 10 μg/mL Anti-TRF2 + TRF1 antibody [TRF-78]. The antibody was developed using Goat Anti-Mouse IgG, Cy3 conjugate. Cells were counterstained with DAPI (blue) to stain nuclei.

Western blot - Anti-TRF2 + TRF1 antibody [TRF-78] (AB10579)
  • WB

Supplier Data

Western blot - Anti-TRF2 + TRF1 antibody [TRF-78] (AB10579)

Anti-TERF antibody [TRF-78] (ab10579) staining at 4 ug/ml, shown in green. In Western blot, ab10579 was shown to bind specifically to TERF. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 5 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Mouse IgG H&L 800CW at 1/20000 dilution.

All lanes:

Western blot - Anti-TRF2 + TRF1 antibody [TRF-78] (ab10579) at 4 µg/mL

Lane 1:

Recombinant Human TRF1 protein cell lysate at 0.1 µg

Lane 2:

Recombinant Human TRF1 protein cell lysate at 0.5 µg

Lane 3:

Empty

Lane 4:

Recombinant Human TRF2 protein cell lysate at 0.1 µg

Lane 5:

Recombinant Human TRF2 protein cell lysate at 0.5 µg

Observed band size: 80 kDa,56 kDa

false

Western blot - Anti-TRF2 + TRF1 antibody [TRF-78] (AB10579)
  • WB

AbReview67699****

Western blot - Anti-TRF2 + TRF1 antibody [TRF-78] (AB10579)

Blocking step

Milk as blocking agent for 2 hours · Concentration : 5% · Temperature : 21°C.

Incubation time

12 hours · Temperature : 4°C · Diluent : 5% milk in TBST.

All lanes:

Western blot - Anti-TRF2 + TRF1 antibody [TRF-78] (ab10579) at 1/1000 dilution

Lane 1:

SAOS2 (Human osteosarcoma cell line) cell lysate at 20 µg

Lane 2:

U-2 OS (Human bone osteosarcoma epithelial cell line) cell lysate at 20 µg

Secondary

All lanes:

Goat anti Mouse polyclonal IRDye 800CW at 1/1000 dilution

Predicted band size: 50 kDa

false

Exposure time: 5min

Verified customer

Western blot - Anti-TRF2 + TRF1 antibody [TRF-78] (AB10579)
  • WB

Supplier Data

Western blot - Anti-TRF2 + TRF1 antibody [TRF-78] (AB10579)

All lanes:

Western blot - Anti-TRF2 + TRF1 antibody [TRF-78] (ab10579) at 4 µg/mL

Lane 1:

HeLa (Human epithelial cell line from cervix adenocarcinoma) nuclear cell lysate

Lane 2:

HeLa cell lysate

Lane 3:

HEK-293T (Human epithelial cell line from embryonic kidney transformed with large T antigen) cell lysate

Lane 4:

U-2 OS (Human bone osteosarcoma epithelial cell line) cell lysate

Lane 5:

HepG2 (Human liver hepatocellular carcinoma cell line) cell lysate

Secondary

All lanes:

Goat Anti-Mouse IgG-Peroxidase

Predicted band size: 50 kDa

false

Western blot - Anti-TRF2 + TRF1 antibody [TRF-78] (AB10579)
  • WB

CiteAb

Western blot - Anti-TRF2 + TRF1 antibody [TRF-78] (AB10579)

TRF2 + TRF1 western blot using anti-TRF2 + TRF1 antibody [TRF-78] ab10579. Publication image and figure legend from Wang, H., Zhang, K., et al., 2017, BMC Biol, PubMed 29216888.

ab10579 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab10579 please see the product overview.

TERF1 expression levels associated with telomere length and pluripotency of human embryonic stem cell (hESCs). a Scheme for hTERF1 knockout by CRISPR/Cas9. b Morphology of TERF1+/- and wild-type (WT) hESCs (WA26) at passage 11. Scale bar = 100 μm. c Expression levels of pluripotency and telomerase genes in TERF1+/- and WT hESCs by qPCR analysis. *p < 0.05, **p < 0.01, compared with WT controls. The data values of each gene are provided in Additional file 18 : Table S10. d Western blot analysis of TERF1, SOX2, and OCT4/POU5F1 protein levels in TERF1+/- and WT hESCs. β-actin served as a loading control. e Cell cycle analysis of TERF1+/- and WT hESCs by flow cytometry. Data represent mean ± SD of three independent experiments. f Telomerase activity by TRAP assay of TERF1+/- and WT hESCs at different passages. U2OS served as a negative control. g Telomere length measurement by southern blot analysis of TERF1+/- and WT hESCs. h Quantification of southern blot results. Data represent mean ± SD of two independent experiments. i Immunofluorescence detection of γH2AX and telomere FISH of TERF1+/- and WT hESCs. j, k Number of telomere-γH2AX colocalization foci per cell (j) and percentage of cells with the colocalization (k). l Relative telomere length of individual TERF1+/- and WT hESCs by scT&R-seq. Right panel shows the mean telomere length by scT&R-seq. m Gene expression measured in single cells of TERF1+/- and WT hESCs by scT&R-seq. Right panel shows the mean level of gene expression. n Linear regression analysis of telomere length and gene expression (TERF1 and NANOG) at single cell level

false

Key facts

宿主種

Mouse

クローン性

Monoclonal

クローン番号

TRF-78

アイソタイプ

IgG1

キャリアフリー

No

交差種

Human

アプリケーション

ICC/IF, WB

applications

免疫原

Full Length Protein corresponding to Human TERF1. The exact immunogen used to generate this antibody is proprietary information.

P54274

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "2-4 µg/mL", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/100", "ICCIF-species-notes": "<p></p>" } } }

製品の詳細

What is this antibody validated in?
Anti-TRF2 + TRF1 antibody [TRF-78] (ab10579) is a mouse monoclonal antibody and is validated for use in Western Blot (WB), Immunocytochemistry/immunofluorescence (ICC/IF) in Human samples.

What is the molecular weight of TRF1?
Anti-TRF2 + TRF1 [TRF-78] (ab10579) specifically detects a band for TRF1 (UniProt: P54274) at a molecular weight of 50kDa.

Trusted by the scientific community
Anti-TRF2 + TRF1 [TRF-78] (ab10579) was first used in a scientific publication in 2004 and has been cited over 60 times in peer-reviewed journals.

Reviewed by scientists
Anti-TRF2 + TRF1 [TRF-78] (ab10579) has over 5 independent reviews from customers.

出荷温度及び保存条件

製品の状態
Liquid
精製方法
Affinity purification Protein G
バッファー組成
pH: 7.4 Preservative: 0.097% Sodium azide Constituents: PBS
出荷温度
Blue Ice
短期保存温度
+4°C
長期保存温度
-20°C
分注に関する情報
Upon delivery aliquot
保管に関する情報
Avoid freeze / thaw cycle

補足情報

This supplementary information is collated from multiple sources and compiled automatically.

TRF2 and TRF1 also known as Telomeric Repeat-binding Factors 2 and 1 are proteins essential for telomere maintenance. TRF2 has a molecular mass of approximately 54 kDa while TRF1 is around 56 kDa. These proteins are ubiquitously expressed across various cell types with significant concentrations in proliferative tissues like bone marrow and testis. Both TRF2 and TRF1 are part of the shelterin complex a critical component in regulating telomere length and protecting chromosome ends.
Biological function summary

The shelterin complex which includes TRF2 and TRF1 plays a pivotal role in telomere integrity. They bind to telomeric DNA preventing end-to-end chromosome fusions and inappropriate activation of DNA damage responses. TRF2 and TRF1 are key to preserving telomere structure by facilitating t-loop configuration. This structural maintenance prevents deleterious genomic instability which could otherwise lead to cellular dysfunction or transformation.

Pathways

TRF2 and TRF1 are integral to the telomere signaling pathway. These proteins coordinate with other shelterin components and are essential in managing telomere-associated checkpoint pathways. TRF2 associates closely with proteins like RAP1 aiding in telomere protection and limiting telomerase access. TRF1 interacts with proteins like TIN2 and POT1 further influencing the telomere maintenance pathways by modulating telomeric DNA accessibility and structural organization.

TRF2 and TRF1 are linked to cancer and aging-related conditions. Dysfunction in these proteins disrupts telomere homeostasis potentially leading to tumorigenesis due to unchecked cell division. In cancer abnormal expression of TRF2 connects to proteins such as ATM which play important roles in DNA damage response and repair pathways. Additionally alterations in TRF1 expression can accelerate cellular aging processes highlighting its significance in age-associated diseases.

製品プロトコール

For this product, it's our understanding that no specific protocols are required. You can visit:

ターゲットの情報

Binds the telomeric double-stranded 5'-TTAGGG-3' repeat and negatively regulates telomere length (PubMed : 31595153). Involved in the regulation of the mitotic spindle. Component of the shelterin complex (telosome) that is involved in the regulation of telomere length and protection. Shelterin associates with arrays of double-stranded 5'-TTAGGG-3' repeats added by telomerase and protects chromosome ends; without its protective activity, telomeres are no longer hidden from the DNA damage surveillance and chromosome ends are inappropriately processed by DNA repair pathways.
See full target information TERF1

追加のターゲット

TERF2

文献 (82)

Recent publications for all applications. Explore the full list and refine your search

Genes & development : PubMed40954016

2025

Mice carrying the homologous human shelterin POT1-L259S mutation linked to pulmonary fibrosis show a telomerase deficiency-like phenotype with telomere shortening with increasing mouse generations.

Applications

Unspecified application

Species

Unspecified reactive species

Raúl Sánchez-Vázquez,Sonia Burgaz García-Oteyza,Rosa Serrano,Juana M Flores,Paula Martínez,Maria A Blasco

Communications biology 7:1099 PubMed39244596

2024

FBXO47 regulates centromere pairing as key component of centromeric SCF E3 ligase in mouse spermatocytes.

Applications

Unspecified application

Species

Unspecified reactive species

Ani Ma,Yali Yang,Lianbao Cao,Lijun Chen,Jian V Zhang

Nucleic acids research 52:11689-11703 PubMed39193906

2024

Elucidation of the molecular mechanism of the breakage-fusion-bridge (BFB) cycle using a CRISPR-dCas9 cellular model.

Applications

Unspecified application

Species

Unspecified reactive species

Manrose Singh,Kaitlin Raseley,Alexis M Perez,Danny MacKenzie,Settapong T Kosiyatrakul,Sanket Desai,Noelle Batista,Navjot Guru,Katherine K Loomba,Heba Z Abid,Yilin Wang,Lars Udo-Bellner,Randy F Stout,Carl L Schildkraut,Ming Xiao,Dong Zhang

The EMBO journal 43:1301-1324 PubMed38467834

2024

ATR limits Rad18-mediated PCNA monoubiquitination to preserve replication fork and telomerase-independent telomere stability.

Applications

Unspecified application

Species

Unspecified reactive species

Siyuan Chen,Chen Pan,Jun Huang,Ting Liu

Cell reports 43:113656 PubMed38194346

2024

Oxidative guanine base damage plays a dual role in regulating productive ALT-associated homology-directed repair.

Applications

Unspecified application

Species

Unspecified reactive species

Sanjana A Thosar,Ryan P Barnes,Ariana Detwiler,Ragini Bhargava,Anne Wondisford,Roderick J O'Sullivan,Patricia L Opresko

Nucleic acids research 51:12242-12260 PubMed37930826

2023

The RNA-binding motif protein 14 regulates telomere integrity at the interface of TERRA and telomeric R-loops.

Applications

Unspecified application

Species

Unspecified reactive species

Yajun Wang,Wei Zhu,Yumi Jang,Joshua A Sommers,Gong Yi,Chandrakala Puligilla,Deborah L Croteau,Yibin Yang,Mihoko Kai,Yie Liu

Nature communications 14:6708 PubMed37872177

2023

Telomouse-a mouse model with human-length telomeres generated by a single amino acid change in RTEL1.

Applications

Unspecified application

Species

Unspecified reactive species

Riham Smoom,Catherine Lee May,Vivian Ortiz,Mark Tigue,Hannah M Kolev,Melissa Rowe,Yitzhak Reizel,Ashleigh Morgan,Nachshon Egyes,Dan Lichtental,Emmanuel Skordalakes,Klaus H Kaestner,Yehuda Tzfati

Asian journal of andrology 26:165-174 PubMed37856231

2023

Caseinolytic mitochondrial matrix peptidase X is essential for homologous chromosome synapsis and recombination during meiosis of male mouse germ cells.

Applications

Unspecified application

Species

Unspecified reactive species

Hai-Wei Feng,Yu Zhao,Yan-Ling Gao,Dong-Teng Liu,Li-Jun Huo

International journal of molecular sciences 24: PubMed37762556

2023

Ginsenoside F1-Mediated Telomere Preservation Delays Cellular Senescence.

Applications

Unspecified application

Species

Unspecified reactive species

Jingang Hou,Yeejin Yun,Byeongmin Jeon,Jongin Baek,Sunchang Kim

Cell reports 42:112329 PubMed37014751

2023

ERCC6L2 mitigates replication stress and promotes centromere stability.

Applications

Unspecified application

Species

Unspecified reactive species

Christopher J Carnie,Lucy Armstrong,Marek Sebesta,Antonio Ariza,Xiaomeng Wang,Emily Graham,Kang Zhu,Dragana Ahel
View all publications

Abcam product promise

当社は、高品質な試薬を通じてお客様の研究を力強くサポートすることをお約束いたします。ご使用いただく各段階で、常にお客様をサポートできる体制を整えております。万が一、製品が期待通りに機能しない場合は、「Abcam Product Promise」による当社保証制度に基づき、安心してご利用いただけます。
保証に関する詳細については利用規約をご確認ください。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com